fda warning letters glp-1 september 2025 news Moderna, Prime Medicine, UnitedHealth: Readout Newsletter FDA Warns Novo Nordisk on

In the suit, Novo added that no head-to-head trials have compared the highest doses of Wegovy and Zepbound currently available on the market, so Lilly has "no basis to make these comparative claims" that its drugs are more effective

This article examines the mechanism of GLP-1 agonists, their potential risks in Crohn's disease, practical management strategies, and alternative weight management options for patients with inflammatory bowel disease

The first step is catalyzed by glutamate-cysteine ligase (GCL), which is composed of catalytic and modifier subunits (GCLC and GCLM)

and L.L.), grant I+D+I PID2022-142074OBI00-RAINBOW funded by MCIN/AEI/10.13039/501100011033/FEDER, UE (to M.A.), Comunidad de Madrid Atraccion de Talento Mod